Skip to content

Drug interactions

Maprotiline + Siponimod

Severity: Moderate

Maprotiline and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Siponimod can cause bradycardia and AV conduction delay after initiation, and QT-prolonging drugs such as maprotiline add to arrhythmic risk. Labeling advises caution with drugs that prolong QT or slow heart rate.

What this interaction means in plain words

Maprotiline and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Maprotiline belongs to Central Nervous System; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive effects of S1P-receptor-mediated bradycardia and drug-induced QT prolongation.

What to do

Obtain an ECG before starting siponimod and consider cardiology advice and extended first-dose monitoring. Monitor heart rate and QTc and correct electrolytes.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maprotiline and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maprotiline with Siponimod?

MediHelp rates the interaction as moderate. Maprotiline and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Siponimod can cause bradycardia and AV conduction delay after initiation, and QT-prolonging drugs such as maprotiline add to arrhythmic risk. Labeling advises caution with drugs that prolong QT or slow heart rate.

How serious is the interaction between Maprotiline and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain an ECG before starting siponimod and consider cardiology advice and extended first-dose monitoring. Monitor heart rate and QTc and correct electrolytes.

What other medicines interact with Maprotiline?

MediHelp also lists interactions of Maprotiline with, for example, Arsenic trioxide, Disopyramide, Dofetilide. The full list is on the Maprotiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in